JP2008508188A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008508188A5 JP2008508188A5 JP2007504792A JP2007504792A JP2008508188A5 JP 2008508188 A5 JP2008508188 A5 JP 2008508188A5 JP 2007504792 A JP2007504792 A JP 2007504792A JP 2007504792 A JP2007504792 A JP 2007504792A JP 2008508188 A5 JP2008508188 A5 JP 2008508188A5
- Authority
- JP
- Japan
- Prior art keywords
- thiazol
- ethyl
- phenyl
- amino
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CCN(*)C(c1ccccc1)=O Chemical compound CCN(*)C(c1ccccc1)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2004904196 | 2004-07-27 | ||
| AU2004904196A AU2004904196A0 (en) | 2004-07-27 | Thiazole Derivatives Having VAP-1 Inhibitory Activity | |
| PCT/JP2005/014136 WO2006011631A2 (en) | 2004-07-27 | 2005-07-27 | Thiazole derivatives having vap-1 inhibitory activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008508188A JP2008508188A (ja) | 2008-03-21 |
| JP2008508188A5 true JP2008508188A5 (enExample) | 2008-08-14 |
| JP4978464B2 JP4978464B2 (ja) | 2012-07-18 |
Family
ID=35734947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007504792A Expired - Fee Related JP4978464B2 (ja) | 2004-07-27 | 2005-07-27 | Ｖａｐ−１阻害剤活性を有するチアゾール誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20070254931A1 (enExample) |
| EP (1) | EP1786792B1 (enExample) |
| JP (1) | JP4978464B2 (enExample) |
| KR (1) | KR20070050932A (enExample) |
| CN (1) | CN101031555A (enExample) |
| AT (1) | ATE427941T1 (enExample) |
| CA (1) | CA2575411A1 (enExample) |
| DE (1) | DE602005013793D1 (enExample) |
| ES (1) | ES2324922T3 (enExample) |
| WO (1) | WO2006011631A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2641734A1 (en) | 2006-02-15 | 2007-08-23 | Abbott Laboratories | Acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| WO2007095603A2 (en) * | 2006-02-15 | 2007-08-23 | Abbott Laboratories | Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| CA2691520A1 (en) * | 2007-06-25 | 2008-12-31 | R-Tech Ueno, Ltd. | Composition for ophthalmic disease associated with hypoxia or ischemia |
| CN101903045B (zh) * | 2007-10-19 | 2013-03-13 | 株式会社·R-技术上野 | 用于治疗白内障的药物组合物 |
| WO2009061830A1 (en) * | 2007-11-06 | 2009-05-14 | Massachusetts Eye & Ear Infirmary | Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor |
| DK2240468T3 (da) * | 2008-01-18 | 2014-01-20 | Allergan Inc | Selektive adrenerge stoffer af undertype alpha 2 og fremgangsmåder til fremstilling heraf |
| TWI437986B (zh) | 2008-01-31 | 2014-05-21 | R Tech Ueno Ltd | 噻唑衍生物及使用該衍生物作為ｖａｐ－１抑制劑之用途 |
| TWI490214B (zh) | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途 |
| UA107917C2 (ru) * | 2008-10-21 | 2015-03-10 | Сімабей Терапьютікс, Інк. | Арильный агонист рецептора gpr120 и его применение |
| UA112154C2 (uk) | 2009-09-08 | 2016-08-10 | Біоті Терапіс Корп. | Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів |
| FI20115234A0 (fi) | 2011-03-08 | 2011-03-08 | Biotie Therapies Corp | Uusia pyridatsinoni- ja pyridoniyhdisteitä |
| PT3002278T (pt) * | 2011-03-15 | 2017-06-29 | Astellas Pharma Inc | Composto de guanidina |
| WO2013057944A1 (ja) | 2011-10-19 | 2013-04-25 | 興和株式会社 | 新規なスピロインドリン化合物、及びそれを含有する医薬 |
| US20160113893A1 (en) | 2013-06-12 | 2016-04-28 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
| HUE042625T2 (hu) | 2014-04-15 | 2019-07-29 | Pecsi Tudomanyegyetem | Szemikarbazid-szenzitiv amin-oxidáz gátlók fájdalomcsillapítóként való alkalmazásra traumás neuropátiában és neurogén gyulladásban |
| WO2015189534A1 (en) | 2014-06-12 | 2015-12-17 | Proximagen Limited | Vap-1 inhibitors for treating muscular dystrophy |
| CN104478828B (zh) * | 2014-12-10 | 2016-07-06 | 漳州片仔癀药业股份有限公司 | 2-氨基-7-取代苯并噻唑类化合物及其制备方法与用途 |
| JOP20200093A1 (ar) | 2015-01-09 | 2017-06-16 | Kyowa Kirin Co Ltd | طريقة لإنتاج مشتق ثيازول |
| JP2018076236A (ja) | 2015-06-05 | 2018-05-17 | 株式会社アールテック・ウエノ | がんを処置するための医薬組成物 |
| JP6809464B2 (ja) * | 2015-08-06 | 2021-01-06 | 宇部興産株式会社 | 置換グアニジン誘導体 |
| JP2019502672A (ja) | 2015-12-07 | 2019-01-31 | ベネボレンタイ ケンブリッジ リミティド | 疼痛の治療のためのｖａｐ−１阻害剤 |
| US9926292B2 (en) * | 2016-05-12 | 2018-03-27 | Boehringer Ingelheim International Gmbh | Pyridinyl derivatives, pharmaceutical compositions and uses thereof |
| RS63103B1 (sr) | 2016-12-28 | 2022-04-29 | Ube Industries | Supstituisana jedinjenja gvanidina |
| US10213306B2 (en) | 2017-03-31 | 2019-02-26 | Neochord, Inc. | Minimally invasive heart valve repair in a beating heart |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1982002384A1 (en) * | 1981-01-08 | 1982-07-22 | Sakano Isao | Their preparation,and medicinal composition containing same |
| US4699928A (en) * | 1984-07-13 | 1987-10-13 | Merrell Dow Pharmaceuticals Inc. | Fluoroallylamine derivatives |
| IT1181871B (it) * | 1985-04-01 | 1987-09-30 | Consiglio Nazionale Ricerche | Inibitori selettivi delle benzilamminossidasi rispetto ad altre amminossidasi |
| US4916151A (en) * | 1985-12-05 | 1990-04-10 | Merrell Dow Pharmaceuticals Inc. | Method of treating parkinson's syndrome |
| US4650907A (en) * | 1985-12-05 | 1987-03-17 | Merrell Dow Pharmaceuticals Inc. | Nonaromatic fluoroallylamine MAO inhibitors |
| US4943593A (en) * | 1988-02-25 | 1990-07-24 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| US4965288A (en) * | 1988-02-25 | 1990-10-23 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| US5021456A (en) * | 1988-02-25 | 1991-06-04 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| US5059814A (en) * | 1988-11-30 | 1991-10-22 | The California Institute Of Technology | Winner-take-all circuits for neural computing systems |
| JPH0848664A (ja) * | 1994-08-05 | 1996-02-20 | Hisamitsu Pharmaceut Co Inc | 新規なグアニジノ安息香酸エステル誘導体 |
| GB9506188D0 (en) * | 1995-03-27 | 1995-05-17 | Fujisawa Pharmaceutical Co | Amidine derivatives |
| AU2001282162A1 (en) * | 2000-07-05 | 2002-01-14 | Biotie Therapies Corp. | Inhibitors of copper-containing amine oxidases |
| AU2002214505A1 (en) * | 2000-11-09 | 2002-05-21 | Biovitrum Ab | New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives |
| CA2514573A1 (en) * | 2003-01-27 | 2004-08-12 | Astellas Pharma Inc. | Thiazole derivatives and their use as vap-1 inhibitors |
| CA2520957C (en) * | 2003-03-31 | 2013-08-06 | Sucampo Ag | Method for treating vascular hyperpermeable disease |
| CA2558135C (en) * | 2004-03-18 | 2012-08-14 | R-Tech Ueno, Ltd. | Aqueous composition comprising thiazole derivative |
-
2005
- 2005-07-27 WO PCT/JP2005/014136 patent/WO2006011631A2/en not_active Ceased
- 2005-07-27 JP JP2007504792A patent/JP4978464B2/ja not_active Expired - Fee Related
- 2005-07-27 CN CNA200580031703XA patent/CN101031555A/zh active Pending
- 2005-07-27 KR KR1020077004487A patent/KR20070050932A/ko not_active Ceased
- 2005-07-27 ES ES05768525T patent/ES2324922T3/es not_active Expired - Lifetime
- 2005-07-27 CA CA002575411A patent/CA2575411A1/en not_active Abandoned
- 2005-07-27 US US11/572,772 patent/US20070254931A1/en not_active Abandoned
- 2005-07-27 DE DE602005013793T patent/DE602005013793D1/de not_active Expired - Lifetime
- 2005-07-27 EP EP05768525A patent/EP1786792B1/en not_active Expired - Lifetime
- 2005-07-27 AT AT05768525T patent/ATE427941T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4978464B2 (ja) | Ｖａｐ−１阻害剤活性を有するチアゾール誘導体 | |
| JP2008508188A5 (enExample) | ||
| JP4650412B2 (ja) | チアゾール誘導体およびｖａｐ−１阻害剤としてのその使用 | |
| AU2009209885B2 (en) | Thiazole derivative and use thereof as VAP-1 inhibitor | |
| JP4758337B2 (ja) | 血管透過性亢進疾患を治療する方法 | |
| US20080015202A1 (en) | Thiazole Derivatives Having Vap-1 Inhibitory Activity | |
| JP2008512346A5 (enExample) | ||
| CN1209352C (zh) | 肼衍生物 | |
| US20110269953A1 (en) | Nitrogen and Sulfur-Containing Heterocycle Derivatives |